Data / Form D filings / Verona Pharma plc
Verona Pharma plc: Form D filings
Verona Pharma plc, a pharmaceuticals company in London, United Kingdom, filed 2 Form D notices with the SEC between 2016 and 2020. The latest, on July 30, 2020, reports $200.2 million sold of a $200.2 million offering to 43 investors.
Find out what Verona Pharma plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 More London Riverside, London, United Kingdom, SE1 2
- Phone
- 011-44-0-2032834200
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1657312
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 30, 2020 | New notice | $200,155,041 | $200,155,041 | $0 | 43 | Jul 22, 2020 | sec.gov |
| Jul 20, 2016 | New notice | $44,524,058 | $44,524,058 | $0 | 8 | Jun 17, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew W. Sinclair | Director | |
| Mahendra W. Shah | Director | |
| Rishi W. Gupta | Director | |
| David W. Ebsworth | Director | |
| Mark W. Hahn | Executive Officer | |
| Kathleen W. Rickard | Executive Officer | |
| Anders W. Ullman | Director | |
| Claire W. Poll | Executive Officer | |
| Martin W. Edwards | Director | |
| Ken W. Cunningham | Director | |
| David Zaccardelli | Executive Officer, Director | |
| Vikas W. Sinha | Director |
Every Form D from the week of Jul 27, 2020 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Verona Pharma plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.